Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,171,104
  • Shares Outstanding, K 21,029
  • Annual Sales, $ 486,820 K
  • Annual Income, $ 18,780 K
  • EBIT $ 72 M
  • EBITDA $ 132 M
  • 60-Month Beta 0.71
  • Price/Sales 2.39
  • Price/Cash Flow 8.61
  • Price/Book 2.87

Options Overview Details

View History
  • Implied Volatility 33.59% ( -6.35%)
  • Historical Volatility 33.59%
  • IV Percentile 25%
  • IV Rank 36.76%
  • IV High 53.01% on 09/18/24
  • IV Low 22.30% on 05/13/24
  • Put/Call Vol Ratio 0.67
  • Today's Volume 5
  • Volume Avg (30-Day) 24
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 404
  • Open Int (30-Day) 441

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.15
  • Number of Estimates 3
  • High Estimate 1.22
  • Low Estimate 1.06
  • Prior Year 0.78
  • Growth Rate Est. (year over year) +47.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.93 +2.17%
on 11/19/24
63.23 -12.86%
on 11/13/24
-5.21 (-8.64%)
since 10/18/24
3-Month
52.53 +4.89%
on 09/11/24
64.21 -14.19%
on 08/30/24
-6.09 (-9.95%)
since 08/20/24
52-Week
48.20 +14.32%
on 12/08/23
70.81 -22.19%
on 03/25/24
+3.80 (+7.41%)
since 11/20/23

Most Recent Stories

More News
FATE Q3 Earnings Beat on Higher Revenues, Pipeline in Focus

Fate Therapeutics FATE reported a loss of 40 cents per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 42 cents. The company reported a loss of 46 cents per...

IMCR : 32.42 (-0.43%)
CSTL : 28.45 (-1.45%)
ANIP : 55.10 (-1.06%)
FATE : 2.22 (+1.83%)
Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up

Axsome Therapeutics, Inc. AXSM incurred an adjusted loss of $1.34 per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of $1.38. The company had incurred a loss...

JAZZ : 119.24 (+2.07%)
CSTL : 28.45 (-1.45%)
ANIP : 55.10 (-1.06%)
AXSM : 94.60 (-0.90%)
SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark

SpringWorks Therapeutics, Inc. SWTX incurred a loss of 72 cents per share in the third quarter of 2024, which was narrower than the Zacks Consensus Estimate of a loss of 76 cents. The company had reported...

IMCR : 32.42 (-0.43%)
CSTL : 28.45 (-1.45%)
ANIP : 55.10 (-1.06%)
SWTX : 37.44 (-1.29%)
Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised

Mirum Pharmaceuticals, Inc. MIRM incurred a loss of 30 cents per share in third-quarter 2024, much narrower than the Zacks Consensus Estimate of a loss of 45 cents. The company had reported a loss of 57...

IMCR : 32.42 (-0.43%)
MIRM : 43.69 (+3.80%)
CSTL : 28.45 (-1.45%)
ANIP : 55.10 (-1.06%)
ANI: Q3 Earnings Snapshot

ANI: Q3 Earnings Snapshot

ANIP : 55.10 (-1.06%)
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

ANIP : 55.10 (-1.06%)
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

ANIP : 55.10 (-1.06%)
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

ANIP : 55.10 (-1.06%)
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

ANIP : 55.10 (-1.06%)
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

ANIP : 55.10 (-1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 57.83
2nd Resistance Point 57.03
1st Resistance Point 56.07
Last Price 55.10
1st Support Level 54.31
2nd Support Level 53.51
3rd Support Level 52.55

See More

52-Week High 70.81
Fibonacci 61.8% 62.17
Fibonacci 50% 59.50
Fibonacci 38.2% 56.84
Last Price 55.10
52-Week Low 48.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar